期刊文献+

心脏再同步治疗无应答原因及预防措施 被引量:4

暂未订购
导出
摘要 心力衰竭(心衰)是危害人类健康的一大杀手,是多种器质性心脏病的晚期表现,严重影响心脏病患者预后和生存率.心脏再同步化治疗(cardiac resynchronizationtherapy,CRT)用于治疗心衰已有10余年,适应证已经从Ⅲ类变为Ⅰ类,越来越多的患者从中获益,但仍有大约30%的患者不能实现临床获益,即置入CRT后患者临床症状无改善,此种现象称为CRT无应答,积极寻找其原因是临床工作者不断探索的目标.本文结合最新的研究进展,从适应证的选择、左室电极置入部位、术后程控、优化药物治疗等方面给予阐述.
作者 张宾 田福利
机构地区 解放军
出处 《中国循证心血管医学杂志》 2013年第2期208-209,共2页 Chinese Journal of Evidence-Based Cardiovascular Medicine
  • 相关文献

参考文献14

  • 1Achili A,Sassara M,Ficili S,et al.Long term effectiveness of cardiac resynchronization therapy in patiens with refractory heart failure and "narrow"QRS[J].J Am Coll Cardiol,2003,42(12):2117.
  • 2Abraham WT,Fisher WG,Smith AL,et al.Cardiac resnchronizationg in chronic heart failure[J].N Engl J Med,2002,346(24):1845-53.
  • 3Woo GW,Petersen-Stejskal S,Johnson JW,et al.Ventricular reverse remodeling and 6-month outcomes in patiens receiving cardiac resynchronization therapy:analysis of the MIRACLE study[J].J Interv Card Electrophysiol,2005,12(2):107-13.
  • 4王涛,王野,张树龙.影响心脏再同步化治疗应答的新认识[J].中国心脏起搏与心电生理杂志,2010,24(2):176-178. 被引量:13
  • 5金炜,李娟.心脏再同步化治疗中的左室起搏部位[J].中国心脏起搏与心电生理杂志,2009,23(4):297-299. 被引量:17
  • 6Kass DA.An epidemic of dyssynchrony:but what does it mean[J].J Am Coll Cardiol,2008,51(1):12-7.
  • 7Swedberg K Anderson B,Leclerq CH,et al.Management of chroic heart failure[M].In Camm JA,Luscher TF,SernuysPW.The ESC Textbook of Caidiovascular Medicine.Maklen Blackwell Publishing Co,2006:721-57.
  • 8Luedorff G,Grove R,Kranig W,et al.Different venous angioplasty manoeuvres for successful implantation of CRT devices[J].Clin ResCardiol,2009,98(3):159.
  • 9汪菁峰,宿燕岗,柏瑾,王蔚,秦胜梅,葛均波.左室起搏电极部位对心脏再同步化治疗疗效的影响[J].中国心脏起搏与心电生理杂志,2012,26(1):22-25. 被引量:10
  • 10Bertini M,Ziacchi M,Biffi M,et al.Interventricular delay interval optimization incardiac resynchronization therapy guided by echocardiography versus guidedby electrocardiographic QRS interval width[J].Am J Cardiol,2008,102(10):1373-7.

二级参考文献53

  • 1John Suiton MG,Plappert T,Abrahan WT,et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure [ J ]. Circulation,2003,107 : 1 985.
  • 2Swedberg K, Anderson B, Leclerq CH, et al. Management of chronic heart failure. In :Camm JA, Luscher TF, Serruys PW, eds. The ESC Textbook of Cardiovascular Medicine[M]. Malden : Blackwell Publishing Co,2006. 721.
  • 3Yu YH, Huvelle E, Spinelli J. Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients[ J ]. Circulation, 2001,104:3 026.
  • 4Nagele H, Hashagen S, Azizi M, et al. Long-term hemodynamic benefit of biventficular pacing depending on coronary sinus lead position [ J ]. Herzschrittmacherther Elektrophysiol, 2006,17 (4) : 185.
  • 5de Cock CC, Vos OH, Jessurun E, et al. Effects of stimulation site on diastolic function in cardiac resynchronization therapy [ J ]. PACE, 2007,30( Suppl 1) :S40.
  • 6Rovner A, de Las Fuentes L, Faddis MN,et al. Relation of left ventricular lead placement in cardiac resynchronization therapy to left ventricularreverse remodeling and to diastolic dyssynchrony[ J ]. Am J Cardiol,2007 ,99 :239.
  • 7Macias A, Gavira J-J, Casta 5 o S,et al. Left ventricular pacing site in cardiac resynchronization therapy: clinical follow-up and predictors of failed lateral implant[J]. European Journal of Heart Failure, 2008,10:4-21.
  • 8Yu CM, Zhang Q, Fung JW, et al. A novel tool to access systolic asynchrony and identify responders of cardiac resynchronization therapy by tissue synchronization imaging [ J ]. J Am Coll Cardiol , 2005,45 ( 5 ) : 677.
  • 9Beshai JF, Grimm RA, Nagueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes[J]. N Engl J Med,2007,357(24) :2 461.
  • 10Lambiase PD, Rinaldi A, Hauck J. Non-contact left ventricular endocardial mapping in cardiac resynehronization therapy [J].Heart,2004,90:44.

共引文献37

同被引文献83

  • 1Stevenson WG, Hernandez AF, Carson PE, et al. Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline Committee. J Card Fail, 2012, 18:94-106.
  • 2Gianfranchi L, Alboni E Cardiac resynchronization therapy: back to ECG?. JCardiovasc Med(Hagerstown), 2010, 11:145-150.
  • 3Shenkman H J, Pampati V, Khandelwal AK, et al. Congestive heart failure and QRS duration establishing prognosis study. CHEST, 2002, 122:528-534.
  • 4Kashani A, Barold SS. Significance of QRS complex duration in patients with heart failure. J Am Coll Cardiol, 2005, 46:2183-2192.
  • 5Dhingra R, Nam BH, Benjamin EJ, et al. Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensionsThe Framingharn Heart Study. J Am Coll Cardiol, 2005, 45:685-689.
  • 6Sandhu R, Bahler RC. Prevalence of QRS prolongation in a community hospital cohort of patients with heart failure and its relation to left ventricular systolic dysfunction. Am J Cardiol, 2004, 93:244-246.
  • 7Baldasseroni S, Opasich C, Gorini M, et al. Left bundle-branch block is associated with increased 1-year sudden and total mortality rate in 5517 outpatients with congestive heart failure: a report from the Italian network on congestive heart failure. Am Heart J, 2002, 143: 398-405.
  • 8Bode-Schnurbus L, B6cker D, Block M, et al. QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failure. Heart, 2003, 89:1157-1162.
  • 9Porciani MC, Cappelli F, Perrotta L, et al. Has mechanical dyssynchrony still a role in predicting cardiac resynchronization therapy response?. Echocardiography, 2010, 27:831-838.
  • 10Gorcsan J 3rd, Yu CM, Sanderson JE. Ventricular resynchronization is the principle mechanism of benefit with cardiac resynchronization therapy. Heart Fail Rev, 2012, 17:737-746.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部